Natco Pharma Adjusts Evaluation Score Amid Mixed Technical Indicators and Performance Trends
Natco Pharma has recently experienced a change in its evaluation score, influenced by technical indicators and market trends. While the sentiment shows a shift, the company continues to demonstrate strong management efficiency and long-term growth, despite recent declines in net sales and profit after tax.
Natco Pharma, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in its evaluation score. This revision reflects a combination of technical indicators and market trends that have influenced the stock's overall assessment.The technical landscape for Natco Pharma indicates a shift in sentiment, with various metrics suggesting a transition from bearish to mildly bearish conditions. The Moving Average Convergence Divergence (MACD) and the Know Sure Thing (KST) indicators are currently positioned in a bearish range, while the Relative Strength Index (RSI) shows a bullish signal on a weekly basis, yet remains neutral on a monthly basis. Additionally, Bollinger Bands are indicating mildly bearish trends for both weekly and monthly periods.
Despite these technical adjustments, Natco Pharma maintains a strong management efficiency, evidenced by a high return on equity (ROE) of 15.27% and a low debt-to-equity ratio. The company has also demonstrated healthy long-term growth, with operating profits increasing at an annual rate of 30.72%. However, recent quarterly results have shown a decline in net sales and profit after tax, contributing to a complex performance narrative.
For those interested in tracking the latest developments, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
